Endometrial cancer: Place for adjuvant chemotherapy;Cancer de l'endomètre: Place de la chimiothérapie adjuvante

Bulletin du Cancer

Volumn 99, Issue 1, 2012, Pages 85-91

  Lheureux, Stéphane ^a   Joly, Florence ^a,b  

^a Francois Baclesse Anticancer Center   (France)

^b CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

Adjuvant chemotherapy; Endometrial cancer

Indexed keywords

CANCER ADJUVANT THERAPY; COMORBIDITY; ENDOMETRIUM CANCER; HIGH RISK PATIENT; REVIEW; RISK ASSESSMENT; TOXICITY; TREATMENT INDICATION; TREATMENT PLANNING;

EID: 84856587329     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2011.1518     Document Type: Article

References (14)

1. INCa. Survie attendue des patients atteints de cancers en France : état des lieux. 2010.
2. Querleu D, Planchamp F, Naducci F, et al. Clinical practice guidelines for the management of patients with endometrial cancer in France: recommendations of the Institut national du cancer and the société française d'oncologie gynécologique. Int J Gynecol Cancer 2011; 21 : 945-50.
3. ASTEC/EN.5 Study Group, Blake P, Swart AM, et al. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. Lancet 2009; 373 : 137-46.
4. Tangjitgamol S, See HT, Kavanagh J. Adjuvant chemotherapy for endometrial cancer. Int J Gynecol Cancer 2011; 21 : 885-95.
5. Morrow CP, Bundy BN, Homesley HD, et al. Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: a Gynecologic Oncology Group Study. Gynecol Oncol 1990; 36 : 166-71. (Pubitemid 20061279)
6. Hogberg T, Signorelli M, de Oliveira CF, et al. Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer - results from two randomised studies. Eur J Cancer 2010; 46 : 2422-31.
7. Kuoppala T, Mäenpää J, Tomas E, et al. Surgically staged high-risk endometrial cancer: randomized study of adjuvant radiotherapy alone vs. sequential chemo-radiotherapy. Gynecol Oncol 2008; 110 : 190-5.
8. Homesley HD, Filiaci V, Gibbons SK, et al. A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: a Gynecologic Oncology Group study. Gynecol Oncol 2009; 112 : 543-52.
9. Randall ME, Filiaci VL, Muss H, et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 2006; 24 : 36-44. (Pubitemid 46630491)
10. Maggi R, Lissoni A, Spina F, et al. Adjuvant chemotherapy vs. radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. Br J Cancer 2006; 95 : 266-71. (Pubitemid 44187586)
11. Susumu N, Sagae S, Udagawa Y, et al. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. Gynecol Oncol 2008; 108 : 226-33. (Pubitemid 350299451)
12. Johnson N, Bryant A, Miles T, Cornes P, Cochrane Gynaecological Cancer Review Group. Systemic Cochrane review examining the role of adjuvant chemotherapy for endometrial cancer. Proceedings of the 13th International Gynecologic Cancer Society; October 23-27, 2010; Prague, Czech Republic. (Abstract 11).
13. Sovak MA, Hensley ML, Dupont J, et al. Paclitaxel and carboplatin in the adjuvant treatment of patients with high-risk stage III and IV endometrial cancer: a retrospective study. Gynecol Oncol 2006; 103 : 451-7. (Pubitemid 44740097)
14. Nomura H, Aoki D, Takahashi F, et al. Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: a Japanese Gynecologic Oncology Group study (JGOG2041). Ann Oncol 2011; 22 : 636-42.